Conferences
EAU 2024: Risk Adapted Screening for Prostate Cancer in Europe: PSA Only - the PROBASE German Screening Trial in Young Men
April 6, 2024
EAU 2024: Defining Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Comparative Study of EAU and IBCG Criteria
April 6, 2024
EAU 2024: Options and Challenges in the Management of Oligometastatic Prostate Cancer in the PSMA-PET Era
April 6, 2024
EAU 2024: Extended Follow-up from CheckMate 274 Including the First Report of Overall Survival Outcomes
April 6, 2024
EAU 2024: Update on PSMA PET/CT: When Does Its Use in Staging Have an Impact on Survival?
April 5, 2024